Cutaneous Metastatic Melanoma

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2023-02-14
Clinical Trial Update: The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma [Phase 2, Phase 3]
A clinical trial investigating intralesional IL-2 and/or BCG for cutaneous metastatic melanoma was withdrawn.